, page 1 sur 4
Supplemental Material
Canada
2Department of gastroenterology, CHU de Québec-Université Laval, Quebec City,
Quebec, Canada
3Lipid Research Center, CHU de Québec-Université Laval, Quebec City, Canada
Online Supporting Material Drouin-Chartier et al., page 2 sur 4
List of the manufacturers of the ELISA kits:
Supplemental Table 2: Correlations between changes in intestinal mRNA levels induced by the substitution of ω-6 PUFAs for
SFAs in intestinal genes involved in lipid and lipoprotein metabolism significantly regulated by the experimental diets
HNF4α PPARα VLDLR MTP ApoB ApoA1 SAR1B ABCG5 ABCG8 FABP2 FATP4 MGAT2
PPARα 0.47† ---
VLDLR -0.32 -0.43* ---
MTP 0.64‡ 0.57† -0.32 ---
ApoB 0.65‡ 0.58‡ -0.47† 0.49† ---
ApoAI 0.48† 0.65‡ -0.41* 0.76‡ 0.58‡ ---
SAR1B 0.74‡ 0.50† -0.34 0.83‡ 0.65‡ 0.72‡ ---
ABCG5 0.69‡ 0.45* -0.48† 0.59† 0.64‡ 0.61‡ 0.54† ---
ABCG8 0.54† 0.46* -0.43* 0.56† 0.44* 0.65‡ 0.53† 0.85‡ ---
FABP2 0.72‡ 0.61‡ -0.34 0.85‡ 0.57† 0.79‡ 0.85‡ 0.53† 0.50† ---
FATP4 0.67‡ 0.62‡ -0.53† 0.71‡ 0.60‡ 0.67‡ 0.79‡ 0.62‡ 0.62‡ 0.75‡ ---
MGAT2 0.56† 0.16 -0.07 0.48† 0.38* 0.13 0.58‡ 0.41* 0.40* 0.46* 0.55† ---
DGAT1 0.82‡ 0.63‡ -0.48† 0.82‡ 0.72‡ 0.77‡ 0.86‡ 0.75‡ 0.69‡ 0.84‡ 0.89‡ 0.48†
A non-parametric Spearman’s rank correlation test was performed to evaluate the associations between key intestinal genes
involved in cholesterol metabolism with respect to changes in mRNA expression levels following the PUFA diet vs. the SFA
diet.
*: P<0.05; †: P<0.01; ‡: P<0.001